Abstract
BackgroundEnd-stage kidney disease (ESKD) is a significant public health concern disproportionately affecting African Americans (AAs). Type 2 diabetes (T2D) is the leading cause of ESKD in the USA, and efforts to uncover genetic susceptibility to diabetic kidney disease (DKD) have had limited success. A prior genome-wide association study (GWAS) in AAs with T2D-ESKD was expanded with additional AA cases and controls and genotypes imputed to the higher density 1000 Genomes reference panel. The discovery analysis included 3432 T2D-ESKD cases and 6977 non-diabetic non-nephropathy controls (N = 10,409), followed by a discrimination analysis in 2756 T2D non-nephropathy controls to exclude T2D-associated variants.ResultsSix independent variants located in or near RND3/RBM43, SLITRK3, ENPP7, GNG7, and APOL1 achieved genome-wide significant association (P < 5 × 10−8) with T2D-ESKD. Following extension analyses in 1910 non-diabetic ESKD cases and 908 non-diabetic non-nephropathy controls, a meta-analysis of 5342 AA all-cause ESKD cases and 6977 AA non-diabetic non-nephropathy controls revealed an additional novel all-cause ESKD locus at EFNB2 (rs77113398; P = 9.84 × 10–9; OR = 1.94). Exclusion of APOL1 renal-risk genotype carriers identified two additional genome-wide significant T2D-ESKD-associated loci at GRAMD3 and MGAT4C. A second variant at GNG7 (rs373971520; P = 2.17 × 10–8, OR = 1.46) remained associated with all-cause ESKD in the APOL1-negative analysis.ConclusionsFindings provide further evidence for genetic factors associated with advanced kidney disease in AAs with T2D.
Highlights
Increasing evidence suggests that genetic factors play a major role in susceptibility to end-stage kidney disease (ESKD)
End-stage kidney disease (ESKD) cases were recruited from the Wake Forest School of Medicine (WFSM) (Affy6.0, Axiom, and Multi-Ethnic Genotyping Array (MEGA)), Family Investigation of Nephropathy and Diabetes (FIND), and Atherosclerosis Risk in Communities Study (ARIC) studies
Controls with Type 2 diabetes (T2D)-lacking nephropathy were more obese than T2D-ESKD or non-diabetic ESKD cases and non-diabetic, non-nephropathy controls, except that T2D-ESKD cases in ARIC were more obese than the other groups
Summary
Increasing evidence suggests that genetic factors play a major role in susceptibility to end-stage kidney disease (ESKD). This is relevant in African Americans (AAs) where incidence rates of ESKD are more than threefold greater than European Americans (EAs) [1]. Of which 95% of patients have type 2 diabetes (T2D), remains the leading reported cause of ESKD in the USA accounting for > 44% of cases [1]. Type 2 diabetes (T2D) is the leading cause of ESKD in the USA, and efforts to uncover genetic susceptibility to diabetic kidney disease (DKD) have had limited success.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have